Physician profile
Barry B Barnes
NPI 1205808961
$457.56
in general payments reported to CMS, 2019-2025
17 companies · $63.03 in 2025
The $63.03 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.91 · 2020: $83.22 · 2021: $133 · 2022: $41.13 · 2023: $60.07 · 2024: $53.19 · 2025: $63.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $51.30 | 2021-2024 | Gattex |
| Misonix INC | $40.24 | 2020 | |
| Ethicon US, LLC | $39.88 | 2020-2021 | |
| Smith+Nephew, INC. | $35.42 | 2019-2020 | |
| Csl Behring | $33.81 | 2021 | |
| Kerecis Limited | $32.33 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $29.57 | 2021 | |
| Solventum Corporation | $27.84 | 2025 | V.A.C.Instill, Activ.A.C., Prevena |
| Organogenesis INC. | $27.74 | 2023 | Puraply |
| Davol INC. | $22.41 | 2021 | |
| Heron Therapeutics, INC. | $19.82 | 2022 | |
| Merck Sharp & Dohme LLC | $19.76 | 2025 | Keytruda, Lynparza |
| Sirius Medical Systems | $18.67 | 2024 | Pintuition |
| Tela Bio, INC. | $16.61 | 2024 | Ovitex 2s |
| Mozarc Medical US LLC | $15.43 | 2025 | Argyle |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $13.74 | 2021 | |
| Biocompatibles, INC. | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.